An announcement from Cochlear Limited ( (AU:COH) ) is now available.
Cochlear Limited is currently seeking clarification on the application of a new 10% tariff imposed by the US on exports from Australia. The company has traditionally benefited from duty-free importation of its hearing implants into the US, and is awaiting further details from US Customs and Border Protection to understand the impact on its operations.
More about Cochlear Limited
Cochlear Limited operates in the medical device industry, specializing in hearing implants. The company focuses on providing innovative solutions for individuals with hearing loss, enhancing their ability to hear and communicate.
YTD Price Performance: -7.64%
Average Trading Volume: 52
Technical Sentiment Signal: Buy
Current Market Cap: $10.79B
For detailed information about COH stock, go to TipRanks’ Stock Analysis page.